Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
Brunnström
Hans
H
Department of Pathology, Institution of Clinical Sciences, Lund University, Sweden. hans.brunnstrom@med.lu.se
Rawshani
Nina
N
Zetterberg
Henrik
H
Blennow
Kaj
K
Minthon
Lennart
L
Passant
Ulla
U
Englund
Elisabet
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D015415:Biomarkers / Q000032:analysis / Q000134:cerebrospinal fluid; D001921:Brain / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D007562:Creutzfeldt-Jakob Syndrome / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000503:physiopathology; D003704:Dementia / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000503:physiopathology; D015140:Dementia, Vascular / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000503:physiopathology; D003937:Diagnosis, Differential; D005260:Female; D057180:Frontotemporal Dementia / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D020961:Lewy Body Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D013548:Sweden; D016875:tau Proteins / Q000134:cerebrospinal fluid
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D016875:tau Proteins